News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer
Deridre Kelly/X
Nov 2, 2024, 19:05

Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer

Deridre Kelly, Medical Oncologist at Mater Misericordiae University Hospital, shared a post on X:

“Immuno Oncology: Anti–PD-L1 and TKI in anaplastic thyroid cancer.

Median OS: 19 mosBRAF V600E-mutated patients: 43 mos (50% ORR)
Longest OS in ATC history!

Targeted and immunotherapy synergy outcomes.”

Deridre Kelly: Anti–PD-L1 and TKI in anaplastic thyroid cancer

cancer Deridre Kelly immuno-oncology JAMA Oncology Maria Cabanillas OncoDaily Oncology thyroid cancer
Special Coverage
Insight
Nov 21, 2024, 06:29
Sami Mansfield: What if improving metabolic health could reduce cancer risks and improve outcomes?
Blog
Nov 21, 2024, 06:27
Julie Gralow: Comprehensive Genomic Profiling Improves Precision Therapy Use And Patient Survival
Insight
Nov 20, 2024, 20:44
Baris Turkbey: Excited to announce NCI Molecular Imaging members presenting their research at RSNA2024
Blog
Nov 20, 2024, 20:38
Franklin Iheanacho: Changing treatment patterns for hepatocellular carcinoma
Insight
Nov 20, 2024, 20:27
HIPEC improves overall survival in recurrent epithelial ovarian cancer
Blog
Nov 20, 2024, 19:12
Medicaid Cancer Foundation at 1Ummah Annual Convention
Insight
Nov 20, 2024, 19:12
Sahar Mansour: Advancing Breast Microcalcification Detection with AI
Blog
Nov 20, 2024, 19:12
Reflecting on Progress and Partnerships in Lung Cancer Care – Sarah Cannon Research Institute
Blog
Nov 20, 2024, 19:12
Virtual tumor board on the management of a patient with Metastatic Squamous NSCLC - IASLC
Insight
Nov 20, 2024, 19:12
Nareg Varjabedian: Antidiabetic Drugs and Cancer Prevention
Insight
Nov 20, 2024, 19:12
Paolo Ciracì: Late-line options for patients with metastatic colorectal cancer
Insight
Nov 20, 2024, 19:12
Physicians’ perspectives on cancer-related fatigue management: A cross-sectional survey study in Germany - MASCC